A SaaS-y startup out of Stanford has developed a wholly-automated chatbot to provide support to sufferers of depression and anxiety via Facebook Messenger on a subscription basis. Dubbed Woebot, the chatbot, developed using Cognitive Behavioral Therapy techniques, “replicates decision-making the way a clinician makes decisions” and can serve as a disease-agnostic platform for provision of emotional support, according to the CEO behind it.
The behemoths of cloud computing – Amazon, Microsoft and Google – are pitching cloud-based, AI-powered services that “automates mundane tasks including data entry, consulting work like patient management and referrals, and even the diagnostic elements of highly skilled fields such as pathology,” according to Bloomberg.
Facebook held an inaugural day for pharmas and their agencies last week, and their head of health vowed to “educate internally to move faster for them—or set any type of guardrails that they might need so that they’re feeling safe and are compliant with all the regulatory and policy constraints that they face.” Per Klick Wire’s notes, there was a lot of talk about data and analytics, and a discussion of ‘lean forward’ and ‘lean back’ approaches to user experience design.
Our friends at Klick surveyed U.S. adults about digital innovation and found high hopes for digital technologies in healthcare, particularly wearables – but they’re not very impressed with the current state of things.
A few years ago, there was talk from some pharma critics of ‘counter-detailing’ doctors to promote the use of lower-cost generics over branded drugs. Now, at least a handful of payers have reportedlybegun hiring pharma reps to do so.
A bill that would amend the Prescription Drug User Fee Act to allow drug companies more communication with HCPs around off-label uses is moving through congress and is expected to get a vote this summer.
Afrezza-maker MannKind is sponsoring a reality show in which a handful of Americans with diabetes gather at a swanky Jamaican resort and try to combat the disease with diet and exercise under the guidance of Bob Marley’s nephew, who conceived of the show as ‘The Biggest Loser meets diabetes.’ MannKind gets ad slots on the Discovery Life show in the bargain, and perhaps a mention.